June 2020

Brickell Biotech Completes $20M Common Stock Offering

United States - Colorado

Faegre Drinker represented Brickell Biotech, Inc., a clinical-stage pharmaceutical company, in a $20 million offering consisting of common stock and warrants. 

The Faegre Baker Daniels website uses cookies to make your browsing experience as useful as possible. In order to have the full site experience, keep cookies enabled on your web browser. By browsing our site with cookies enabled, you are agreeing to their use. Review Faegre Baker Daniels' cookies information for more details.